CG Invites Co., Ltd. (KOSDAQ:083790)
1,271.00
+1.00 (0.08%)
Apr 29, 2026, 3:30 PM KST
CG Invites Revenue
In the year 2025, CG Invites had annual revenue of 27.39B KRW with 277.64% growth. CG Invites had revenue of 12.00B in the quarter ending December 31, 2025, with 338.87% growth.
Revenue
27.39B
Revenue Growth
+277.64%
P/S Ratio
3.57
Revenue / Employee
260.87M
Employees
105
Market Cap
97.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.39B | 20.14B | 277.64% |
| Dec 31, 2024 | 7.25B | 2.37B | 48.67% |
| Dec 31, 2023 | 4.88B | 557.33M | 12.90% |
| Dec 31, 2022 | 4.32B | -38.05B | -89.80% |
| Dec 31, 2021 | 42.38B | 12.15B | 40.21% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IMB Dx | 5.33B |
| Oncocross | 370.46M |
| GeneOne Life Science | 23.04B |
| iNtRON Biotechnology | 5.74B |
| Amicogen | 41.98B |
| ORIENT BIO | 59.09B |
| ENCell | 5.26B |
| Vaxcell-Bio Therapeutics | 1.90B |